Touro University Nevada

The Touro College and University System
Not a member yet
    19043 research outputs found

    Milvexian: A Focus on a New Oral Anticoagulant That Targets Factor Xia for Thromboembolism Prophylaxis

    No full text
    Drugs that target factor XI and/or XIa have been evaluated as alternatives to existing anticoagulants, in light of studies that indicate that a decrease in Factor XI/XIa levels or activity may result in a lower risk of thrombosis without a significant increase in bleeding risk. Milvexian is an investigational small-molecule factor XIa inhibitor that has recently completed phase 2 clinical trials. Preclinical studies were suggestive of its potential to prevent arterial and venous thrombosis. It was well-tolerated in healthy participants, as well as in participants with mild or moderate hepatic impairment and moderate or severe renal impairment. Notably, patients who received milvexian after knee arthroplasty had a dose-proportional lower incidence of venous thromboembolism compared to patients who received postoperative enoxaparin, and they had a lower incidence of clinically relevant bleeding. A separate phase 2 trial was conducted that assessed the use of milvexian for secondary stroke prevention in patients who had ischemic stroke or transient ischemic attack. It failed its primary objective of establishing a dose-response relationship between milvexian and a composite endpoint of symptomatic ischemic stroke or covert brain infarction. The trial did, however, show a reduction in the relative risk of symptomatic ischemic stroke across most of the treatment groups receiving various dosages of milvexian compared to placebo. The efficacy of milvexian in secondary stroke prevention will be further assessed in an upcoming phase 3 trial. Additional upcoming phase 3 trials will also assess its efficacy in stroke prevention in patients with atrial fibrillation as well as in event reduction in patients with acute coronary syndrome

    Integration of an Audiovisual Learning Resource in a Podiatric Medical Infectious Disease Course: Multiple Cohort Pilot Study

    No full text
    Background: Improved long-term learning retention leads to higher exam scores and overall course grades, which is crucial for success in preclinical coursework in any podiatric medicine curriculum. Audiovisual mnemonics, in conjunction with text-based materials and an interactive user interface, have been shown to increase memory retention and higher order thinking. Objective: This pilot study aims to evaluate the effectiveness of integrating web-based multimedia learning resources for improving student engagement and increasing learning retention. Methods: A quasi-experimental study was conducted with 2 cohorts totaling 158 second-year podiatric medical students. The treatment group had access to Picmonic’s audiovisual resources, while the control group followed traditional instruction methods. Exam scores, final course grades, and user interactions with Picmonic were analyzed. Logistic regression and correlation analyses were conducted to examine the relationships between Picmonic access, performance outcomes, and student engagement. Results: The treatment group (n=91) had significantly higher average exam scores (P\u3c.001) and final course grades (P\u3c.001) than the control group (n=67). Effect size for the average final grades (d=0.96) indicated the practical significance of these differences. Logistic regression analysis revealed a positive association between Picmonic access with an odds ratio of 2.72 with a 95% confidence interval, indicating that it is positively associated with the likelihood of achieving high final grades. Correlation analysis revealed a positive relationship (r=0.25, P=.02) between the number of in-video questions answered and students’ final grades. Survey responses reflected increased student engagement, comprehension, and higher user satisfaction (3.71 out of 5 average rating) with the multimedia-based resources compared to traditional instructional resources. Conclusions: This pilot study underscores the positive impact of animation-supported web-based instruction on preclinical medical education. The treatment group, equipped with Picmonic, exhibited improved learning outcomes, enhanced engagement, and high satisfaction. These results contribute to the discourse on innovative educational methods and highlight the potential of multimedia-based learning resources to enrich medical curricula. Despite certain limitations, this research suggests that animation-supported audiovisual instruction offers a valuable avenue for enhancing student learning experiences in medical education

    Nutraceuticals and Headache 2024: Riboflavin, Coenzyme Q10, Feverfew, Magnesium, Melatonin, and Butterbur

    No full text
    Purpose of Review: Nutraceuticals are not regulated by the US Food and Drug Administration, so a careful literature review is essential to make clinical decisions. Summary: Riboflavin or vitamin B2 can be recommended for migraine prevention in adults, but pediatric use is not proven. Adverse events are minimal. Coenzyme Q10 has Level C evidence for migraine prevention and low adverse events. Feverfew may be effective for migraine prevention, but the absence of clear safety studies, the differences in doses and characteristics of dried leaf preparations, and the myriad of feverfew cellular effects suggest caution in recommendation for use. Magnesium is recommended for migraine prevention and intravenous acute use, with the potential for generally mild gastrointestinal tolerability adverse events. Melatonin has very low certainty for evidence of efficacy, and is weakly recommended in those with sleep problems. However, purity of US sold melatonin is very poor. Butterbur or petasites preparations have strong evidence for efficacy and concern for hepatotoxicity. Please see the US National Center for Complementary and Integrative Health/NIH online site https://www.nccih.nih.gov/health/butterbur for up-to-date recommendations on whether to use this nutraceutical

    SHSP Dean\u27s Newsletter, Summer 2025

    No full text

    Four Seasons from the Bear Mountain Bridge

    No full text
    In every season, I visited the Bear Mountain Bridge and captured the same view of a southbound Amtrak train gliding along the east side of the Hudson River on its journey to Penn Station in New York City. Traveling alongside the Hudson, Amtrak forms an essential part of the passenger commute between places like Burlington, VT; Chicago, IL; Albany, NY; and New York City. I enjoyed exploring this area throughout all four seasons, and I hope this photo conveys some of my excitement and appreciation for its natural beauty. // 2024-202

    Epilepsy: Etiology and Treatment Methods

    No full text
    Epilepsy is a common neurological disorder that is caused by abnormal electrical activity in the brain. Due to the evolution of our understanding of epilepsy and its causes, a variety of therapeutic options have been developed to modulate seizures and limit their occurrence rate. Medication, diet and surgery have been the traditional treatments offered to individuals suffering from epilepsy but the latest advancements in neurotechnology have given patients with drug resistant epilepsy hope by providing options other than surgery. While the disorder is a complex one and its pathogenesis not yet fully understood, recent research has provided insight into the causes of epilepsy, such as genetic predisposition, infection, and metabolic disorders. New research is exploring novel treatments for epilepsy, such as gene and stem cell therapy. These developments, and our current ability to make specialized treatment plans for every patient, provide hope for the millions of people who suffer from epilepsy

    Which of the Environmental Aspects Affecting the Gut Microbiome of the Neonate Has the Largest Lifelong Impact?

    No full text
    The development of new DNA sequencing techniques has led to new discoveries on the gut microbiome’s critical influence on metabolic processes and immune development. Therefore, understanding the most influential factors in the development of the gut microbiome during early infancy, which impacts the individual’s long-term health, is vital. This paper explores how environmental factors, including delivery method and nutrition, shape the gut microbiome’s devel- opment in early life. In addition, it discusses their long-term health implications. The paper highlights how the mode of delivery significantly affects initial microbial colonization. Vaginal births promote a microbial community that is rich in beneficial bacteria like Bifidobacterium. In contrast, C-section deliveries often lead to a microbiome resembling skin flora, which may predispose infants to dysbiosis and subsequent health issues like asthma and obesity. Furthermore, breastfeeding enhances the establishment of a healthy microbiome compared to formula feeding. This is due to the presence of prebiotics and immunoglobulins that support beneficial bacteria growth. The paper also emphasizes the effects of antibiotic exposure on the infant gut microbiome. This can result in reduced microbial diversity, altered metabolic functions, and an increased risk of antibiotic-resistant infections. In contrast, prebiotics and probiotics are found to mitigate dysbiosis and promote a healthy gut microbiome. More research is necessary to establish the long-term health outcomes of neonatal exposure to antibiotics, prebiotics, and probiotics. To better understand the connection between dysbiosis and specific diseases, future research should investigate the mech- anisms by which environmental factors shape the microbiome and their long-term health implications. Ultimately, this study underscores the importance of understanding these factors to promote optimal gut health in infants, potentially mitigating risks associated with dysbiosis and related disorders

    3,119

    full texts

    19,043

    metadata records
    Updated in last 30 days.
    The Touro College and University System
    Access Repository Dashboard
    Do you manage Open Research Online? Become a CORE Member to access insider analytics, issue reports and manage access to outputs from your repository in the CORE Repository Dashboard! 👇